Hypoxia-Treated Extracellular Matrix for Stem Cell Adhesion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for tissue repair using stem cells and extracellular matrices face challenges with cell adhesion and survival, leading to inefficient tissue repair, particularly due to the high cost and difficulty of implementing adhesion peptides, and the need for improved proliferation and differentiation of mesenchymal stem cells.
Innovation Solution
A method involving the use of a hypoxia-treated extracellular matrix, derived from biological tissue, combined with stem cells, to enhance adhesion, proliferation, and differentiation, utilizing a hydrophilic and porous biocompatible synthetic matrix, which promotes cell adhesion and tissue repair by regulating HIF-1α and HIF-2α heterodimers and stimulating angiogenic factors.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If adhesion peptides are added to the matrix to improve cell adhesion, then cell adhesion is enhanced, but the cost increases significantly and the implementation becomes difficult
Solution Approach 1:
The patent changes the chemical parameters of the matrix by treating it with glutaraldehyde, which introduces aldehyde groups that can form covalent bonds with amino groups on cell surface proteins. This chemical modification enables cell adhesion without requiring expensive adhesion peptides, thus resolving the contradiction between improving cell adhesion and reducing implementation difficulty/cost
Solution Approach 2:
The patent uses a simple, inexpensive chemical treatment (glutaraldehyde) instead of expensive, complex adhesion peptides. The glutaraldehyde treatment creates a durable cell-adhesive surface on the matrix that is both cost-effective and easy to implement, directly addressing the contradiction between effectiveness and ease of manufacture
2Reliability
If adhesion peptides are added to the matrix to improve cell adhesion, then cell adhesion is enhanced, but the dosage control becomes difficult and may cause too strong adhesion
Solution Approach 1:
The patent transforms the adhesion mechanism from peptide-based (requiring precise dosage control) to chemistry-based (glutaraldehyde crosslinking). The glutaraldehyde treatment creates a controlled, uniform adhesive surface through chemical reactions with matrix proteins, eliminating the need for precise peptide dosage control while preventing excessive adhesion through controlled reaction conditions
Solution Approach 2:
The glutaraldehyde treatment enables the matrix to self-adhere to cells through spontaneous chemical reactions between aldehyde groups and amino groups on cell surfaces. This self-adhesive property eliminates the need for external adhesion peptides and their associated dosage control problems, allowing the matrix to regulate its own adhesion properties
3Ease of operation
If stem cells are injected without proper adhesion support, then the procedure is simple, but cell survival is poor and tissue repair is ineffective
Solution Approach 1:
The patent applies glutaraldehyde treatment to the matrix in advance before cell injection. This preliminary chemical modification creates a cell-adhesive surface that will support cell survival during and after injection. The adhesion-promoting treatment is performed beforehand, allowing simple injection procedures while ensuring high cell survival rates through the pre-prepared adhesive matrix
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method effectively promotes the adhesion, proliferation, and differentiation of stem cells at tissue repair sites, enhancing tissue repair efficiency while being simple, rapid, and cost-effective, with improved cell survival and angiogenesis.
Implementation Method 1
said matrix is subjected to a hypoxia treatment before said mixing
Implementation Method 2
utilizing a hydrophilic and porous biocompatible synthetic matrix, which promotes cell adhesion and tissue repair by regulating HIF-1α and HIF-2α heterodimers
Implementation Method 3
stimulating angiogenic factors
Implementation Method 4
utilizing a hydrophilic and porous biocompatible synthetic matrix
Implementation Method 5
utilizing a hydrophilic and porous biocompatible synthetic matrix
Data Source
Figure 1
Figure 2~3
Figure 4~5
AI summary
The invention relates to a method for producing a composition to be injected into a biological tissue for tissue repair, by mixing stem cells and a matrix selected from an extracellular matrix obtained from a portion of isolated biological tissue and a porous, positively charged hydrophilic biocompatible synthetic matrix, in which said matrix is subjected to hypoxic treatment before said mixing.